Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001478007-26-000002

Director acquired 6,408 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Klein Peter S Director 2026-06-03 Grant or award +6,408 33,941 D
Derivatives
Klein Peter S Director 2026-06-03 Grant or award · Stock Option (right to buy) +19,226 19,226 D
Loading xslF345X06/wk-form4_1780692356.xml…